All In Biotech

Drug Trial Radar · NCT06386744

Dusquetide for the Treatment of Behcet's Disease

Pilot Study of SGX945 (Dusquetide) in the Treatment of Aphthous Ulcers in Behcet's Disease

Last checked: Nov 20, 2026Latest source record: Aug 26, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

8

Actual

Start

Nov 18, 2024

Primary completion

May 23, 2025

Study completion Jun 17, 2025

Sponsor

Lead sponsor
SoligenixIndustry
Sponsor type
Industry
First posted
Apr 26, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a clinical study to see if dusquetide can treat flares of oral and genital ulcers caused by Behcet's Disease. Study participants will receive an infusion of dusquetide twice a week for 4 weeks (8 treatments total), with weekly follow-up visits for an additional 4 weeks.

Conditions

  • Behçet Disease

Interventions

  • DusquetideDrug

    1.5 mg/mL dusquetide administered as a 4 minute IV infusion, twice per week for 4 weeks

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Oral UlcersTime frame: 4 weeks
  2. Number of Genital UlcersTime frame: 4 weeks

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Istanbul University - Cerrahpasa, Cerrahpasa School of Medicine

    Istanbul, Turkey (Türkiye)

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.